Suvi T. M. Orr

1.0k total citations
6 papers, 273 citations indexed

About

Suvi T. M. Orr is a scholar working on Pharmacology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Suvi T. M. Orr has authored 6 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Molecular Biology and 2 papers in Pharmaceutical Science. Recurrent topics in Suvi T. M. Orr's work include Pharmacogenetics and Drug Metabolism (3 papers), Chemical Reactions and Isotopes (2 papers) and Receptor Mechanisms and Signaling (2 papers). Suvi T. M. Orr is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Chemical Reactions and Isotopes (2 papers) and Receptor Mechanisms and Signaling (2 papers). Suvi T. M. Orr collaborates with scholars based in United States and United Kingdom. Suvi T. M. Orr's co-authors include Hao Sun, Amit S. Kalgutkar, R. Scott Obach, T. Eric Ballard, Dennis O. Scott, Sharon L. Ripp, Jaclyn L. Henderson, Rachael V. Gallagher, L H Patterson and Tracy Robson and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Suvi T. M. Orr

6 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suvi T. M. Orr United States	6	129	114	67	57	37	6	273
Thien-Duc Tran United Kingdom	6	136 1.1×	167 1.5×	35 0.5×	52 0.9×	34 0.9×	7	325
Upendra P. Dahal United States	12	94 0.7×	177 1.6×	74 1.1×	86 1.5×	47 1.3×	17	320
Elyse M. Petrunak United States	12	136 1.1×	179 1.6×	57 0.9×	57 1.0×	30 0.8×	14	393
James P. Driscoll United States	10	110 0.9×	131 1.1×	30 0.4×	83 1.5×	46 1.2×	21	379
Kaushik Mitra United States	15	126 1.0×	197 1.7×	56 0.8×	228 4.0×	71 1.9×	31	516
Andrei Voznesensky United States	7	132 1.0×	104 0.9×	103 1.5×	18 0.3×	31 0.8×	10	242
Kenneth Crawford United States	13	107 0.8×	241 2.1×	93 1.4×	313 5.5×	23 0.6×	16	615
Yuhsin Kuo United States	9	80 0.6×	130 1.1×	78 1.2×	48 0.8×	24 0.6×	15	292
Janet Caceres‐Cortes United States	12	44 0.3×	175 1.5×	95 1.4×	88 1.5×	19 0.5×	24	283
Kuo-Chi Cheng United States	14	74 0.6×	128 1.1×	29 0.4×	147 2.6×	30 0.8×	22	440

Countries citing papers authored by Suvi T. M. Orr

Since Specialization

Citations

This map shows the geographic impact of Suvi T. M. Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suvi T. M. Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suvi T. M. Orr more than expected).

Fields of papers citing papers by Suvi T. M. Orr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suvi T. M. Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suvi T. M. Orr. The network helps show where Suvi T. M. Orr may publish in the future.

Co-authorship network of co-authors of Suvi T. M. Orr

This figure shows the co-authorship network connecting the top 25 collaborators of Suvi T. M. Orr. A scholar is included among the top collaborators of Suvi T. M. Orr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suvi T. M. Orr. Suvi T. M. Orr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Sun, Hao, David W. Piotrowski, Suvi T. M. Orr, et al.. (2018). Deuterium isotope effects in drug pharmacokinetics II: Substrate-dependence of the reaction mechanism influences outcome for cytochrome P450 cleared drugs. PLoS ONE. 13(11). e0206279–e0206279. 24 indexed citations

2.

Kalgutkar, Amit S., Tim F. Ryder, Gregory S. Walker, et al.. (2013). Reactive Metabolite Trapping Studies on Imidazo- and 2-Methylimidazo[2,1-b]thiazole-Based Inverse Agonists of the Ghrelin Receptor. Drug Metabolism and Disposition. 41(7). 1375–1388. 5 indexed citations

3.

Orr, Suvi T. M., Sharon L. Ripp, T. Eric Ballard, et al.. (2012). Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks. Journal of Medicinal Chemistry. 55(11). 4896–4933. 162 indexed citations

4.

Fernando, Dilinie P., Wenhua Jiao, Jana Polívková, et al.. (2012). Spiroazetidine–piperidine bromoindane as a key modular template to access a variety of compounds via C–C and C–N bond-forming reactions. Tetrahedron Letters. 53(47). 6351–6354. 7 indexed citations

5.

Orr, Suvi T. M., Shawn Cabral, Dilinie P. Fernando, & Teresa W. Makowski. (2011). One-pot synthesis of chiral azetidines from chloroaldehyde and chiral amines. Tetrahedron Letters. 52(28). 3618–3620. 7 indexed citations

6.

Patterson, L H, S. R. McKeown, Tracy Robson, et al.. (1999). Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.. PubMed. 14(6). 473–86. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact